Pharmacogenomics (PGx) is moving from research and specialty clinics into routine care. Pharmacists — particularly in community and health-system settings — are uniquely…
Healthcare is changing, and genetics is helping lead the way. Pharmacogenomics, or PGx, looks at how a person’s genes affect the way they…
On October 30, 2025, the U.S. Food and Drug Administration quietly made a major update to the label for capecitabine (Xeloda®). It now…
Artificial intelligence is beginning to find its footing in one of medicine’s most nuanced frontiers: pharmacogenomics — the science of matching medications to…
Pharmacogenomics—the study of how genes affect a person’s response to drugs—is transforming modern medicine. By tailoring drug treatments based on genetic profiles, it…
Efavirenz has helped millions of people living with HIV achieve viral suppression, especially in countries where access to newer antiretroviral drugs remains limited….
FOR IMMEDIATE RELEASE Seasoned Business Writer with Two-Decade History Brings Deep Industry Market Expertise to Lead APGxA’s Digital Content Strategy SAN LUIS OBISPO,…
The COVID-19 pandemic has posed unprecedented challenges, prompting a critical inquiry: Might our genetic makeup hold the key to more effective treatments in…
Explore the challenges and future of cancer pharmacogenetics as we delve into personalized medicine’s role in oncology treatment.
Explore how pharmacogenomics for drug dosing in children is revolutionizing personalized medicine and ensuring safer, effective treatments.
End of content
End of content
Join Our Insider’s Circle! Stay up to Date with the latest in PGx